Skip to content

ACRoss-AMI

ACh-induced Coronary Spasm Study Nifedipine and Benidipine After Acute Myocardial Infarction - ACRoss-AMI

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs071180056
Enrollment
130
Registered
2019-03-18
Start date
2013-08-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction Acute Myocardial Infarction

Interventions

After the treatments for the acute phase of myocardial Infarction,Ach-provocation test is performed for the patients that an agreement by a patient was provided. The patients who are positive and nega

Sponsors

Kaikita Koichi
Lead Sponsor
Ishii Masanobu
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients with ST elevation and non-ST elevation myocardial infarction underwent primary percutaneous coronary intervention (PCI) using the drug eluting stent (DES) or bare metal stent (BMS), who meets all the following eligibility criteria. 1 The patients who are performed ACh-provocation test at 2 weeks after admission and no residual organic stenosis needing PCI 2 Man and woman at the range from 20-85years old at the time of informed consent 3 The case that informed consent by a patient was provided in a document

Exclusion criteria

Exclusion criteria: 1. Patient with unstable angina 2. Patients with triple vessel disease 3. Patients with left ventricular systolic dysfunction (Ejection fraction <40%) 4. Patients with chronic atrial fibrillation 5. Patients with severe liver dysfunction 6. Patients who are intolerable with dihydropyridine based calcium channel blockers 7. Patients with prior PCI using DES8 8. Patients whom the chief physician judged to be inappropriate for study enrollment

Design outcomes

Primary

MeasureTime frame
A rate of changes in ACh-provoked coronary constrictive response and degree of coronary vascular tone at the follow-up coronary angiogram at 6-12 months after primary PCI

Secondary

MeasureTime frame
1. Incidence of coronary spasm at the 2nd ACh-provocation test 2. Changes in biomarkers 3. Cardiovascular events (cardiovascular death, non-fatal MI, unstable angina, rehospitalization for heart failure, re-PCI,etc) 4. Adverse effects 5. Coronary lesion finding by optical coherence tomography (OCT) (if possible)

Contacts

Public ContactKoichi Kaikita

Kumamoto University Hospital

kaikitak@kumamoto-u.ac.jp+81-96-373-5175

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026